
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260919
DTEND;VALUE=DATE:20260920
DTSTAMP:20251217T231732Z
CREATED:20251217T231720Z
LAST-MODIFIED:20251217T231732Z
UID:10000506-1789776000-1789862399@oncodaily.com
SUMMARY:OPN California North Chapter Conference 2026
DESCRIPTION:The 2026 OPN California North Chapter Conference is a one-day regional summit tailored for hematology and oncology pharmacy clinicians\, including pharmacists and pharmacy technicians. \nOrganized by the Oncology Pharmacy Network (OPN) in collaboration with Horizon CME\, the conference focuses on the latest evidence-based strategies in cancer care and provides a platform for professional networking and collaboration. The event is part of a series of regional meetings aimed at optimizing patient outcomes through advanced pharmaceutical insights.
URL:https://oncodaily.com/event/opn-california-430229
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Blvd\, Burlingame\, CA\, 94010\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/OPN-California-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260920
DTEND;VALUE=DATE:20260926
DTSTAMP:20251214T210155Z
CREATED:20251214T210141Z
LAST-MODIFIED:20251214T210155Z
UID:10000494-1789862400-1790380799@oncodaily.com
SUMMARY:ACORD Workshop 2026
DESCRIPTION:The Australia and Asia Pacific Clinical Oncology Research Development (ACORD) Workshop 2026\, presented by the Medical Oncology Group of Australia (MOGA)\, is a prestigious six-day residential program dedicated to advancing clinical cancer research across the Asia-Pacific region. \nScheduled to take place from September 20-25\, 2026\, at the Novotel Sydney Olympic Park in NSW\, Australia\, the workshop is designed for early-career clinical cancer researchers – including medical\, surgical\, radiation oncology\, palliative care\, and allied health professionals – who are near the end of their training or within five years post-specialization. \nParticipants are selected through a competitive process based on the quality and feasibility of a proposed research concept\, and the program focuses on intensive protocol development group sessions\, one-to-one faculty mentorship\, and lectures by leading local and international experts.
URL:https://oncodaily.com/event/acord-428408
LOCATION:Novotel Sydney Olympic Park\, 11A Olympic Blvd\, Sydney Olympic Park\, NSW (New South Wales)\, 2127\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ACORD-Workshop-2026.webp
ORGANIZER;CN="Medical Oncology Group of Australia (MOGA)":MAILTO:moga@moga.org.au
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260925
DTSTAMP:20251117T112111Z
CREATED:20251117T112047Z
LAST-MODIFIED:20251117T112111Z
UID:10000367-1790035200-1790294399@oncodaily.com
SUMMARY:EACR Liquid Biopsies 2026
DESCRIPTION:The European Association for Cancer Research (EACR) conference\, “Liquid Biopsies 2026\,” will take place in Lyon\, France\, from September 22–24\, 2026. This conference will gather world-leading experts to explore the latest advances in circulating nucleic acids\, circulating tumour cells (CTCs)\, and extracellular vesicles (EVs) across the entire cancer continuum. \nThe educational program is structured into four focused sessions – Localised Cancers\, Metastatic Cancers\, Technology\, and Biology – to bridge technological innovation (including fragmentomics and spatial transcriptomics) with biological insights and clinical translation\, ultimately aiming to accelerate the integration of liquid biopsy approaches into cancer care for improved patient outcomes. \nRegister.
URL:https://oncodaily.com/event/liquid-biopsies-411054
LOCATION:L’Ecole Normale Supérieure de Lyon\, 15 parvis René Descartes\, Lyon\, Auvergne-Rhône-Alpes\, 69342\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/LiBi26_all_banners3-1.jpg
ORGANIZER;CN="European Association for Cancer Research":MAILTO:jane.smith@eacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260922
DTEND;VALUE=DATE:20260926
DTSTAMP:20260722T131211Z
CREATED:20260722T131014Z
LAST-MODIFIED:20260722T131211Z
UID:10000813-1790035200-1790380799@oncodaily.com
SUMMARY:AACR Pediatric Cancer Conference: Bridging Discovery and Clinical Impact
DESCRIPTION:Organized by the American Association for Cancer Research (AACR) in association with the AACR Pediatric Cancer Working Group\, the AACR Special Conference in Cancer Research: Bridging Discovery and Clinical Impact in Pediatric Cancer\, will take place on 22–25 September 2026 at Hilton Philadelphia at Penn’s Landing in Philadelphia\, Pennsylvania. \nThe conference will bring together experts in pediatric oncology\, cancer biology\, and translational research to explore immunotherapy\, tumor biology\, developmental pathways\, precision medicine\, genomics\, inherited cancer predisposition\, and the tumor microenvironment. The programme aims to accelerate the translation of scientific discoveries into more effective and less toxic treatments for children with cancer. The advance registration deadline is 11 August 2026. \nRegister Now.
URL:https://oncodaily.com/event/pediatric-cancer-548527
LOCATION:Hilton Philadelphia at Penn’s Landing\, 201 S. Christopher Columbus Blvd\, Philadelphia\, PA\, 19106\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/1779050842312.webp
ORGANIZER;CN="American Association for Cancer Research":MAILTO:aacr@aacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260923
DTEND;VALUE=DATE:20260926
DTSTAMP:20251213T012856Z
CREATED:20251213T012834Z
LAST-MODIFIED:20251213T012856Z
UID:10000483-1790121600-1790380799@oncodaily.com
SUMMARY:The 25th International Cancer Imaging Society Meeting and Annual Teaching Course
DESCRIPTION:The 25th International Cancer Imaging Society Meeting and Annual Teaching Course (ICIS 2026) is an in-person event scheduled for September 23–25\, 2026\, starting at 7:45 AM\, at The Europa Hotel in Belfast\, Northern Ireland. \nCo-hosted with the Faculty of Radiologists and Radiation Oncologists of the Royal College of Surgeons in Ireland (RCSI)\, the conference theme is “Fundamentals of Imaging Cancer with Automated Assistance\,” aiming to reaffirm core cancer imaging principles while highlighting the growing role of automated and AI-driven techniques in clinical practice. \nThe program will feature keynote lectures\, plenary sessions\, hands-on workshops\, and scientific presentations\, all intended to improve participants’ understanding of precision imaging\, advanced interventions\, and clinical reporting skills.
URL:https://oncodaily.com/event/cancer-imaging-society-426886
LOCATION:Europa Hotel\, Great Victoria St\, Belfast\, Northern Ireland\, BT2 7AP\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ICIS-2026.webp
ORGANIZER;CN="International Cancer Imaging Society (ICIS)":MAILTO:admin@cancerimagingsociety.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260923T093000
DTEND;TZID=America/Halifax:20260923T141000
DTSTAMP:20260607T154100Z
CREATED:20260607T154100Z
LAST-MODIFIED:20260607T154100Z
UID:10000744-1790155800-1790172600@oncodaily.com
SUMMARY:NCCN Academy for Excellence And Leadership in Oncology
DESCRIPTION:The NCCN Academy for Excellence & Leadership in Oncology: School of Pharmaceutical and Biotech Business will take place on Wednesday\, September 23\, 2026\, from 9:30 AM to 2:10 PM MDT. This interactive\, in-person training program will be hosted at Le Meridien Denver Downtown in Denver\, Colorado. \nDesigned for pharmaceutical and biotechnology professionals\, the session explores the oncology space\, future trends\, and current operational issues from provider\, advocacy\, and payer perspectives. Participants will improve their working knowledge of key business\, policy\, coverage\, and reimbursement challenges\, gaining critical insights from key stakeholders to navigate the cancer care ecosystem and build successful industry relationships. \nRegister Now.
URL:https://oncodaily.com/event/nccn-516785
LOCATION:Le Meridien Denver Downtown\, 1475 California Street\, Denver\, CO\, 80202\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/d2dd2f22db6145039a188449ea5a05e5.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260924
DTEND;VALUE=DATE:20260927
DTSTAMP:20250805T175214Z
CREATED:20250805T175157Z
LAST-MODIFIED:20250805T175214Z
UID:10000236-1790208000-1790467199@oncodaily.com
SUMMARY:World Cancer Congress 2026
DESCRIPTION:The World Cancer Congress 2026 will be held from September 24 to 26\, 2026\, in Hong Kong\, organized by the Union for International Cancer Control (UICC) in collaboration with the Hong Kong Anti-Cancer Society. This biennial event attracts thousands of participants from over 130 countries\, including global cancer experts\, policymakers\, researchers\, and advocates. \nIt focuses on advancing cancer control through knowledge exchange\, innovative research\, prevention\, treatment\, and policy discussions. World Cancer Congress 2026 will feature plenary sessions\, workshops\, and networking opportunities aimed at fostering collaboration and transformative progress in cancer care and prevention worldwide. Hong Kong’s advanced healthcare facilities and strategic location make it an ideal host for this significant global cancer event
URL:https://oncodaily.com/event/world-cancer-congress-2026-342132
LOCATION:Piedmont
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/08/OncoDaily-30.png
ORGANIZER;CN="Union for International Cancer Control":MAILTO:info@uicc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260924
DTEND;VALUE=DATE:20260927
DTSTAMP:20260609T121918Z
CREATED:20260609T121850Z
LAST-MODIFIED:20260609T121918Z
UID:10000759-1790208000-1790467199@oncodaily.com
SUMMARY:Australian and New Zealand Society of Palliative Medicine Conference (ANZSPM 2026)
DESCRIPTION:The Australian and New Zealand Society of Palliative Medicine Conference (ANZSPM 2026) will be held from September 24 to September 26\, 2026\, at the historic Albert Hall in Launceston\, Tasmania.  \nLed by Conference Organising Committee Chair Dr. Odette Spruijt alongside the ANZSPM President Dr. Michelle Gold and Board\, this premier biennial meeting centers around the theme “Creative Solutions: Thinking Outside the Square.” \nThe three-day operational program celebrates both specialist and generalist medical practitioners delivering expert palliative care across Australia and New Zealand\, showcasing innovative\, person-centered strategies to enhance healthcare delivery. Attendees will engage with leading international and national experts through dynamic scientific sessions\, dedicated Special Interest Group topics\, and premium networking events\, including the official Welcome Reception and Conference Dinner. \nAbstract Submission Deadline: Friday 15th May\, 2026 \nRegister now.
URL:https://oncodaily.com/event/palliative-medicine-517818
LOCATION:Albert Hall Launceston\, 47 Tamar Street\, Launceston\, Tasmania\, 7250\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/d84e2f908df742f8a24fadec3475cb29.webp
ORGANIZER;CN="Australian and New Zealand Society of Palliative Medicine":MAILTO:info@anzspm.org.au
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260924
DTEND;VALUE=DATE:20261001
DTSTAMP:20260728T153946Z
CREATED:20260728T153917Z
LAST-MODIFIED:20260728T153946Z
UID:10000840-1790208000-1790812799@oncodaily.com
SUMMARY:Immuno 2026: Global Virtual Congress on Immuno Oncology
DESCRIPTION:The Immuno 2026 Global Virtual Congress on Immuno-Oncology\, presented by OncoDaily in partnership with the Parker Institute for Cancer Immunotherapy\, will take place online from 24–30 September 2026. \nThe international congress will bring together experts in cancer immunology\, immunotherapy\, translational research\, clinical oncology\, and patient advocacy to examine the next generation of immune-based cancer treatments. Key topics will include checkpoint inhibitor resistance\, cellular therapies for hematologic and solid tumors\, personalized cancer vaccines\, tumor antigen discovery\, biomarker-driven treatment selection\, combination immunotherapy\, and immune-related toxicity management. \nThrough expert presentations\, disease-specific sessions\, panel discussions\, rapid-fire research talks\, and global perspectives\, the event will connect scientific discovery with clinical practice while also marking the Parker Institute’s 10th anniversary and its contribution to collaborative cancer immunotherapy research. \nRegister Now.
URL:https://oncodaily.com/event/553555
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/IMG_7305-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260924T080000
DTEND;TZID=America/Halifax:20260924T180000
DTSTAMP:20260608T143358Z
CREATED:20260608T143358Z
LAST-MODIFIED:20260608T143358Z
UID:10000754-1790236800-1790272800@oncodaily.com
SUMMARY:2nd Annual International Brain and Spine Tumor Symposium
DESCRIPTION:The 2nd Annual International Brain and Spine Tumor Symposium will take place on Thursday\, September 24\, 2026\, at the Jack and Sheryl Morris Cancer Center in New Brunswick\, New Jersey.  \nHosted by the Rutgers Cancer Institute and supported by the New Jersey Pediatric Hematology Oncology Research Center of Excellence (NJ PHORCE)\, this educational forum bridges adult and pediatric neuro-oncology across the lifespan. The case-based program focuses on connectome-guided surgery\, advanced precision radiotherapy\, molecular diagnostics\, and multidisciplinary survivorship planning to optimize long-term clinical and neurocognitive outcomes for brain and spine tumor patients. \nRegister now.
URL:https://oncodaily.com/event/spine-tumor-517453
LOCATION:Jack & Sheryl Morris Cancer Center\, 165 Somerset Street\, New Brunswick\, NJ\, 08901\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/5b42ba99ad6b4d4b92599404c24a3434.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20260928
DTSTAMP:20260627T142318Z
CREATED:20260627T142318Z
LAST-MODIFIED:20260627T142318Z
UID:10000778-1790294400-1790553599@oncodaily.com
SUMMARY:European School of Oncology's Master in Sarcoma
DESCRIPTION:The ESO Master in Sarcoma is a 15-month academic programme developed by the European School of Oncology in collaboration with the Università Campus Bio-Medico di Roma\, designed to advance the clinical and scientific expertise of professionals working in sarcoma management. \nAwarding 60 ECTS credits upon completion\, the programme combines 10 online modules\, two in-person seminars\, an internship\, and a thesis. Participants are also eligible to enrol in ESO College. \n\nApplications opened: March 2026\nApplication deadline: 1 June 2026\nProgramme start: September 2026\nSeminar 1: 25–27 September 2026 — Rome\, Italy\nSeminar 2: March 2027 — ESMO Sarcoma and Rare Cancers Congress\, Lugano\, Switzerland
URL:https://oncodaily.com/event/sarcoma-529658
LOCATION:Università Campus Bio-Medico di Roma\, Via Álvaro del Portillo\, 21\, Rome\, 00128\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/d83fcce6fb63469c9eca24df586aa35a.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20270103
DTSTAMP:20260620T133549Z
CREATED:20260620T133549Z
LAST-MODIFIED:20260620T133549Z
UID:10000766-1790294400-1798934399@oncodaily.com
SUMMARY:European School of Oncology's Refresher Course on Sarcoma
DESCRIPTION:The European School of Oncology’s Refresher Course on Sarcoma is an advanced educational event taking place from 25 to 27 September 2026 in Rome\, Italy. \nOrganized in collaboration with the Università Campus Bio-Medico di Roma\, the program is led by Course Chair Sylvie Bonvalot (FR)\, Host Chair Bruno Vincenzi (IT)\, and College Representative Silvia Brotea-Mosoiu (RO). \nThe curriculum provides a comprehensive review of soft tissue sarcomas alongside bone\, desmoid\, pediatric\, GIST\, and uterine subtypes. It focuses directly on the WHO classification\, molecular biology\, advanced imaging\, biopsy techniques\, surgical quality standards\, and radiotherapy sequencing. Through interactive\, faculty-led clinical case discussions\, the course equips attending specialists with evidence-based strategies to optimize multidisciplinary decision-making and advance personalized patient care. \n 
URL:https://oncodaily.com/event/sarcoma-524499
LOCATION:Università Campus Bio-Medico di Roma\, Via Álvaro del Portillo\, 21\, Rome\, 00128\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/649120323_1236242505289553_8154662109148234054_n.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260926
DTEND;VALUE=DATE:20260928
DTSTAMP:20260126T012123Z
CREATED:20260126T012117Z
LAST-MODIFIED:20260126T012123Z
UID:10000625-1790380800-1790553599@oncodaily.com
SUMMARY:Oncology Learning Network Great Debates in Solid Tumors\, New York City 2026
DESCRIPTION:The Oncology Learning Network Great Debates in Solid Tumors conference will hold its second 2026 installment from September 26–27 in New York City. \nOrganized by HMP Global\, this meeting serves as an official gathering for the Oncology Learning Network\, offering a comprehensive program that focuses on the latest advancements and clinical debates in treating solid tumors\, including gastrointestinal\, lung\, breast\, gynecologic\, and genitourinary cancers. The event is designed for a broad professional audience\, with registration tiers available for healthcare professionals\, students\, residents\, and pharmaceutical industry personnel. \nRegister. \n 
URL:https://oncodaily.com/event/oncology-learning-network-447036
LOCATION:New York City
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/OLN-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260926
DTEND;VALUE=DATE:20261001
DTSTAMP:20251028T221520Z
CREATED:20251028T221457Z
LAST-MODIFIED:20251028T221520Z
UID:10000297-1790380800-1790812799@oncodaily.com
SUMMARY:ASTRO Annual Meeting 2026
DESCRIPTION:The 68th ASTRO Annual Meeting of the American Society for Radiation Oncology will be held from September 26 to September 30\, 2026\, in Boston\, Massachusetts\, with both in-person and on-demand options. This event is the premier gathering for the global radiation oncology community\, serving as the central platform for discussing the latest advances in radiation therapy research\, clinical practice\, and technology. It attracts oncologists\, physicists\, biologists\, and other healthcare professionals who focus on improving cancer treatment through targeted radiation delivery. \nKey preparatory dates for the event include the opening of the Call for Education Sessions on November 6\, 2025\, and the opening of the Call for Abstracts on December 2\, 2025. These submissions are crucial in shaping the scientific and educational program\, ensuring the event highlights the most innovative research and clinical trials set to impact patient care and future practice guidelines in the field of radiation oncology. \nYou can find more posts featuring ASTRO on OncoDaily.
URL:https://oncodaily.com/event/astro-399778
LOCATION:Boston Convention and Exhibition Center\, 415 Summer Street\, Boston\, MA\, 02210\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/ASTRO.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261001
DTSTAMP:20260721T145557Z
CREATED:20260721T145538Z
LAST-MODIFIED:20260721T145557Z
UID:10000809-1790640000-1790812799@oncodaily.com
SUMMARY:ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026
DESCRIPTION:The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 29–30 September 2026 in Lugano\, Switzerland. \nThe course will focus on managing cancer-related symptoms\, cachexia\, nutritional needs\, treatment toxicities\, palliative care\, end-of-life preparation\, and communication with patients and families. Applications close on 26 July 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 11 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodaily.com/event/cancer-patients-2026-547812
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-06_43_45-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261002
DTSTAMP:20260317T121005Z
CREATED:20260317T195222Z
LAST-MODIFIED:20260317T121005Z
UID:10000544-1790640000-1790899199@oncodaily.com
SUMMARY:Society for Integrative Oncology (SIO) 2026 Conference
DESCRIPTION:The Society for Integrative Oncology 23rd International Conference is a hybrid scientific symposium scheduled for September 29 – October 1\, 2026\, in Detroit\, Michigan. \nHosted in collaboration with the Henry Ford Health Center and co-chaired by Dr. Eleanor Walker and Dr. Suzie Zick\, the conference centers on the theme “Cultivating Community and Belonging in Integrative Oncology.” This multidisciplinary meeting provides a technical forum for oncologists\, researchers\, and allied health professionals to examine evidence-based integrative therapies\, including lifestyle medicine\, mind-body interventions\, and nutritional science. \nThe program emphasizes the practical application of integrative care to improve patient outcomes and addresses the importance of health equity and inclusive community-building within the global oncological landscape.
URL:https://oncodaily.com/event/society-for-integrative-oncology-436352
LOCATION:MGM Grand Detroit\, 1777 3rd Ave\, Detroit\, MI\, 48226\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/SIO.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261002
DTSTAMP:20260718T134134Z
CREATED:20260718T134134Z
LAST-MODIFIED:20260718T134134Z
UID:10000791-1790640000-1790899199@oncodaily.com
SUMMARY:ESSO Hands-on Course on Surgical Technique – Abdominal Surgery
DESCRIPTION:The Hands-on Course on Surgical Technique – Abdominal Surgery\, organized by the European Society of Surgical Oncology (ESSO) took place from 29 September to 1 October 2026 at Leiden University Medical Centre in the Netherlands. \nThis Level 1 international workshop combined hands-on cadaveric dissection\, expert lectures\, video-based learning\, and interactive discussions to strengthen participants’ knowledge of abdominal surgical anatomy and oncological surgical techniques. \nPractical training covered abdominal and thoracic surgical access\, vascular approaches\, and the Kocher and Cattell–Braasch manoeuvres\, with a strong emphasis on safe and effective operative practice. \nBecome a Member.
URL:https://oncodaily.com/event/abdominal-surgery-544129
LOCATION:Leiden University Medical Centre\, Albinusdreef 2\, Leiden\, South Holland\, 2333 ZA\, Netherlands
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-17-2026-05_35_41-PM.webp
ORGANIZER;CN="European Society of Surgical Oncology":MAILTO:info@essoweb.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260929T180000
DTEND;TZID=America/Halifax:20260929T190000
DTSTAMP:20260724T120226Z
CREATED:20260724T120226Z
LAST-MODIFIED:20260724T120226Z
UID:10000818-1790704800-1790708400@oncodaily.com
SUMMARY:SPCC - Explore How AI is Reshaping Oncology
DESCRIPTION:The live webinar “Explore How AI Is Reshaping Oncology\, from Foundational Concepts to Future Applications”\, organized by Sharing Progress in Cancer Care (SPCC)\, will take place on 29 September 2026 from 18:00 to 19:00 CEST\, with CME accreditation in progress. The session will examine how artificial intelligence is currently supporting diagnostic accuracy\, clinical workflows\, therapeutic decision-making\, and precision oncology\, while also considering its future role in cancer care. Aleksandra Filipovic will discuss key AI contributions to precision oncology\, followed by Rebecca Romanò on current applications and future perspectives. Pietro Presti will moderate the webinar\, which will conclude with a discussion\, Q&A\, and closing remarks. The session is part of the SPCC Sustaining Corporate Programme 2026. \nLog In for the Webinar.
URL:https://oncodaily.com/event/ai-is-reshaping-oncology-550018
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/Image-12-1-1280x720-1-1.webp
ORGANIZER;CN="Sharing Progress in Cancer Care (SPCC)":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
DTSTAMP:20260127T204424Z
CREATED:20260127T204408Z
LAST-MODIFIED:20260127T204424Z
UID:10000636-1790726400-1790812799@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday\, September 30\, 2026\, starting at 18:30 CEST. \nAs uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma\, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens of daily practice. \nChaired by Olivier Michielin\, the session features a multidisciplinary expert panel including Jorja Braden\, Sophie Piperno-Neumann\, Erick Saldanha\, and Mauricio Fernando Silva Almeida Ribeiro. The program focuses on translating recent breakthroughs – such as the efficacy of tebentafusp – into practical clinical strategies\, addressing implementation barriers\, and utilizing molecular profiling to optimize patient management. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-448014
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260303T101152Z
CREATED:20260303T101152Z
LAST-MODIFIED:20260303T101152Z
UID:10000680-1790899200-1791071999@oncodaily.com
SUMMARY:2026 International Symposium of Gastrointestinal Oncology (ISGIO)
DESCRIPTION:The 2026 International Symposium of Gastrointestinal Oncology (ISGIO)\, hosted by Physicians’ Education Resource\, LLC\, will be held from October 2–3\, 2026\, at the W Fort Lauderdale in Florida. This premier two-day multidisciplinary conference is dedicated to the latest breakthroughs in gastrointestinal (GI) cancer research and the evolving treatment landscape. Led by program co-chairs Dr. Tanios Bekaii-Saab and Dr. Eileen M. O’Reilly\, the symposium utilizes case-based learning\, expert debates\, and panel discussions to help clinicians navigate complex clinical trial data and translate emerging evidence into personalized patient care. \nRegister now.
URL:https://oncodaily.com/event/gastrointestinal-oncology-463751
LOCATION:W Fort Lauderdale\, 401 North Fort Lauderdale Beach Boulevard\, Fort Lauderdale\, FL\, 33304\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-03T141114.437.webp
ORGANIZER;CN="Physicians' Education Resource":MAILTO:onc-info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260721T160010Z
CREATED:20260721T160010Z
LAST-MODIFIED:20260721T160010Z
UID:10000811-1790899200-1791071999@oncodaily.com
SUMMARY:ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on treatment sequencing\, the biology of metastatic breast cancer\, targeted therapy safety and adverse-event management\, and multidisciplinary approaches to improving patient outcomes. Applications close on 21 August 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 10 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodaily.com/event/metastatic-breast-cancer-2026-547927
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-07_50_11-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260721T161206Z
CREATED:20260721T161206Z
LAST-MODIFIED:20260721T161206Z
UID:10000812-1790899200-1791071999@oncodaily.com
SUMMARY:ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC
DESCRIPTION:The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026\, oorganized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC\, biomarker-driven treatment using NGS\, immunohistochemistry\, and liquid biopsy\, and emerging therapies such as antibody–drug conjugates\, bispecific antibodies\, cellular therapies\, and vaccines. It will also address multidisciplinary management of oligometastatic disease and brain metastases. Applications close on 10 August 2026 at 23:59 CEST\, and non-local participants may receive a travel grant of up to €600. \nApply Now.
URL:https://oncodaily.com/event/advanced-nsclc-547940
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-08_06_59-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261005
DTSTAMP:20251226T221942Z
CREATED:20251226T221928Z
LAST-MODIFIED:20251226T221942Z
UID:10000532-1790899200-1791158399@oncodaily.com
SUMMARY:29th British Oncology Pharmacy Association (BOPA) Annual Conference
DESCRIPTION:The 29th British Oncology Pharmacy Association (BOPA) Annual Conference is a key scientific meeting for oncology pharmacy professionals\, scheduled for October 2–4\, 2026\, at the ICC London Olympia. \nThe symposium focuses on the technical and clinical advancements in cancer pharmacy\, featuring a peer-reviewed scientific program that covers therapeutic updates\, service delivery innovation\, and clinical research in oncology.
URL:https://oncodaily.com/event/british-oncology-pharmacy-association-434589
LOCATION:ICC London Olympia\, Hammersmith Rd\, London\, Greater London\, W14 8UX\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BOPA.webp
ORGANIZER;CN="British Oncology Pharmacy Association (BOPA)":MAILTO:membership@bopa.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261007
DTSTAMP:20260607T150448Z
CREATED:20260607T150448Z
LAST-MODIFIED:20260607T150448Z
UID:10000740-1791158400-1791331199@oncodaily.com
SUMMARY:2026 NCCN 2-Day Fall Policy Summit
DESCRIPTION:The 2026 NCCN 2-Day Fall Policy Summit is scheduled for Monday\, October 5 – Tuesday\, October 6\, 2026\, at the National Press Club in Washington\, D.C. \nThe event features a new two-day format with options to attend virtually or in person\, gathering patients\, providers\, payers\, policymakers\, advocates\, and industry leaders to discuss the current landscape of cancer screening and prevention services. The summit will explore population- and individual-level advancements\, current infrastructure capabilities for high-risk populations\, and policy-level challenges\, including the role of USPSTF guidelines and efforts to reduce cost barriers for diagnostic services. Key topics will also feature disparities in screening\, infrastructure funding\, emerging innovations like AI and blood-based tests\, and initiatives aligned with the Trump Administration’s Make America Healthy Again agenda. \nRegister Now.
URL:https://oncodaily.com/event/nccn-516756
LOCATION:National Press Club in Washington\, D.C\, 529 14th St NW\, Washington\, DC 20045\, Washington
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/BeFunky-collage-2026-06-07T190215.141.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261008
DTSTAMP:20260323T191952Z
CREATED:20260323T110020Z
LAST-MODIFIED:20260323T191952Z
UID:10000709-1791158400-1791417599@oncodaily.com
SUMMARY:Global Cardio-Oncology Summit (GC-OS) 2026
DESCRIPTION:The 2026 Global Cardio-Oncology Summit (GC-OS) will be held from October 5–7\, 2026\, in Williamsburg\, Virginia.  \nHosted by the International Cardio-Oncology Society (IC-OS)\, this premier interdisciplinary event is centered on the theme “Cardio-Oncology Innovation and Implementation for the Future.” It serves as a global platform for cardiologists\, oncologists\, and researchers to address the cardiovascular challenges faced by cancer survivors. \nThe scientific program focuses on cutting-edge clinical frontiers\, including the integration of artificial intelligence in diagnostics\, new treatments for cardiac amyloidosis\, and the role of the immune system in cardiovascular health. Key sessions will cover multimodality cardiac imaging\, next-generation therapies in hematology\, and evidence-based exercise interventions designed to mitigate cardio-toxicity. \nBeyond the core lectures\, the summit emphasizes global networking and early-career development through the Young Investigator Award competition on October 7. Set in the historic Williamsburg Inn\, the event balances rigorous academic exchange with the cultural backdrop of one of the U.S.’s most significant historical sites\, providing an ideal environment for professional collaboration and the presentation of original research.
URL:https://oncodaily.com/event/cardio-oncology-473405
LOCATION:Williamsburg Inn\, 136 Francis St E\, Williamsburg\, VA\, 23185\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-23T145341.350.webp
ORGANIZER;CN="International Cardio-Oncology Society (IC-OS)":MAILTO:StephenCasselli@ic-os.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261009
DTSTAMP:20260609T080948Z
CREATED:20260608T204856Z
LAST-MODIFIED:20260609T080948Z
UID:10000756-1791158400-1791503999@oncodaily.com
SUMMARY:The 16th World Clinical Biomarkers and Companion Diagnostics Summit
DESCRIPTION:The landmark World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston at a pivotal moment for precision medicine. With rapid advances in genomic testing\, companion diagnostics\, digital pathology\, spatial omics\, multimodal analytics\, and AI-enabled platforms\, the summit will bring together more than 850 senior stakeholders across biopharma\, diagnostics\, regulatory\, healthcare\, CRO\, testing lab\, and technology communities to accelerate drug-diagnostic innovation and improve patient access to precision care. \nEvent Name: 16th World Clinical Biomarkers & Companion Diagnostics Summit  \nEvent Date: October 5-8\, 2026 \nEvent Venue: The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA 02210 \nRecent regulatory shifts\, followed by a surge in Rx-Dx launches\, expanded access in advanced genomic testing\, rapid innovation in digital pathology\, spatial omics\, multimodal analytics and agentic AI diagnostic platforms\, alongside sustained\, sizeable investments\, signal that precision medicine is entering a defining new era. \nIt is in this context that the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston\, as your longest-standing definitive forum uniting the complete precision medicine ecosystem. Boasting an audience of 850+ senior stakeholders from biopharma\, diagnostic\, regulatory\, healthcare\, CRO\, testing labs and multimodal communities\, this remains the place to strengthen and build the necessary collaborations to accelerate drug-diagnosti  innovations from bench to bedside. \nBe the first to see the newly released 4-day program. \nTo reflect the complex nature and rapid acceleration of novel endpoints and IVD advances\, this year’s meeting will expand to five dedicated content tracks. \n\nBiomarker Discovery & Translation: Equip your translation development\, biomarker discovery\, biomarker operations and oncology teams with the insights needed to validate novel\, highly translatable biomarker panels for both solid tissue and liquid biopsy diagnostic strategies.\nClinical & CDx Development: Aimed at clinical development\, medical affairs\, CDx development\, strategic partnerships and regulatory teams\, this content will provide you with the toolkit to deliver compliant clinical trials\, enrolment and monitoring workflows.\nRx-Dx Commercialization & Adoption: Provide your pricing\, reimbursement\, market access\, HOER and commercialization teams with access to the latest industry shifts and international payer evidence needs\, to ensure rapid synchonrised\, global adoption.\nDigital Pathology & Spatial Biomarkers: Designed for digital pathology\, imaging\, spatial biology and CDx development teams\, this new track will dive into best-in- class ways to standardize analysis\, boost throughput and improve reproducibility.\nMultimodal & AI-Enabled Precision Medicine: Offer your data science\, RWE\, AI & analytics and digital innovation teams\, the chance to hear the cutting-edge data driving and ML-enabled biomarker discovery\, clinical insights\, and precision endpoints.\n\nConvene with peers\, benchmark strategies\, forge new connections\, stay informed on the latest industry trends and streamline your co development pipeline\, at the industry’s leading touchpoint for precision medicine professionals. \nTogether let’s bring accessible\, affordable precision healthcare to patients quicker. \nAttendance is free* for drug developers and researchers. \n*Subject to eligibility and Ts and Cs: visit the website to learn more.
URL:https://oncodaily.com/event/16th-world-clinical-biomarkers-517593
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA 02210\, The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/OncoDiaily.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261006
DTEND;VALUE=DATE:20261009
DTSTAMP:20251117T110913Z
CREATED:20251117T110848Z
LAST-MODIFIED:20251117T110913Z
UID:10000365-1791244800-1791503999@oncodaily.com
SUMMARY:EACR Conference on Cancer Metabolism
DESCRIPTION:The European Association for Cancer Research (EACR) Conference on Cancer Metabolism will be held in Bilbao\, Spain\, from October 6–8\, 2026. This conference focuses on metabolic reprogramming\, a key hallmark of tumors\, and the metabolic alterations that cancer and stromal cells undergo to meet energetic demands\, survive in hostile environments\, and modify their niche. \nThe meeting will gather top experts to discuss the mechanisms through which metabolites regulate cell decisions\, the metabolic interaction between the tumor and the host\, and explore undocumented metabolic alterations in cancer. It targets basic and translational scientists and clinicians\, aiming to provide a broad and detailed overview of the most recent advances in the field. \nRegister.
URL:https://oncodaily.com/event/eacr-411028
LOCATION:The Euskalduna Conference Centre\, Abandoibarra Etorb.\, 4\, Abando\, Bilbao\, Bizkaia\, 48011\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/WhatsApp-Image-2025-11-17-at-15.06.47.jpeg
ORGANIZER;CN="European Association for Cancer Research":MAILTO:jane.smith@eacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261006T000000
DTEND;TZID=Europe/Paris:20261008T153000
DTSTAMP:20260221T093949Z
CREATED:20260221T093949Z
LAST-MODIFIED:20260221T093949Z
UID:10000657-1791244800-1791473400@oncodaily.com
SUMMARY:The Early Detection of Cancer Conference 2026
DESCRIPTION:The Early Detection of Cancer Conference 2026 is set to convene from October 6–8 at the Edinburgh International Conference Centre (EICC) in Scotland.  \nCo-hosted by Cancer Research UK and the OHSU Knight Cancer Institute\, this premier three-day summit serves as a global focal point for the International Alliance for Cancer Early Detection (ACED). \nThe program is designed to transcend traditional research presentations\, featuring high-stakes “Great Debates” and multidisciplinary panels that bridge the gap between discovery biology and clinical implementation. Bringing together a diverse community of scientists\, clinicians\, and industry leaders\, the 2026 meeting will prioritize the translation of cutting-edge technologies—including AI-driven diagnostics and multi-cancer early detection (MCED) tests—into equitable healthcare solutions aimed at identifying cancer at its most treatable stages.
URL:https://oncodaily.com/event/cancer-458938
LOCATION:Edinburgh International Conference Centre (EICC)\, 150 Morrison St\, Edinburgh\, EH3 8EE
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-21T134019.723.webp
ORGANIZER;CN="Cancer Research UK":MAILTO:supporter.services@cancer.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261006T180000
DTEND;TZID=America/Halifax:20261006T190000
DTSTAMP:20260724T121622Z
CREATED:20260724T121501Z
LAST-MODIFIED:20260724T121622Z
UID:10000819-1791309600-1791313200@oncodaily.com
SUMMARY:SPCC Webinar 2026: How Supportive Care Can Improve Cancer Survival
DESCRIPTION:The live webinar “Supportive Care Enhances Patient Survival”\, organized by Sharing Progress in Cancer Care (SPCC)\, will take place on 6 October 2026 from 18:00 to 19:00 CEST\, with CME accreditation in progress. \nThe session will explore how exercise\, nutrition\, symptom management\, and integrative oncology can improve quality of life\, treatment delivery\, and clinical outcomes for people with cancer. Julie Gralow will discuss the role of exercise in oncology\, while Andreas Charalambous will examine how integrating symptom management into cancer care may contribute to improved survival. Matti Aapro and Karim Nagui will co-chair the webinar\, which will also include a discussion\, Q&A\, and closing remarks. The session is part of the SPCC Corporate Programme on Integrative Oncology. \nLogin for the Webinar.
URL:https://oncodaily.com/event/spcc-webinar-2026-550038
LOCATION:
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/spcc-e1731076868159-800x477-1-1.webp
ORGANIZER;CN="Sharing Progress in Cancer Care (SPCC)":MAILTO:info@spcc.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261010
DTSTAMP:20260720T151856Z
CREATED:20260720T151732Z
LAST-MODIFIED:20260720T151856Z
UID:10000804-1791417600-1791590399@oncodaily.com
SUMMARY:4th International Conference on Innovations and Advances in Cancer Research and Treatment - UICC
DESCRIPTION:The 4th International Conference\, on Innovations and Advances in Cancer Research and Treatment – Cancer 2026\, organized by Scitechseries\, will take place on 8–9 October 2026 at ANA Crowne Plaza Narita in Chiba\, Japan. \nUnder the theme “Empowering Global Collaboration in Cancer Care\,” the conference will bring together researchers\, oncologists\, geneticists\, engineers\, and other specialists to discuss advances in cancer research\, precision medicine\, emerging therapies\, and innovative technologies. The programme will include keynote lectures\, oral and poster presentations\, panel discussions\, and more than 20 thematic tracks. Accepted conference proceedings will be peer-reviewed and published in Archives in Oncology Research with DOI assignment. \n 
URL:https://oncodaily.com/event/4th-international-conference-on-innovations-546784
LOCATION:ANA Crowne Plaza Narita\, 68 Horinouchi\, Narita\, Chiba\, 286-0107\, Japan
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-06_48_15-PM.webp
ORGANIZER;CN="Scitechseries":MAILTO:info@scitechseries.com
END:VEVENT
END:VCALENDAR